Identification of novel microRNAs negatively regulating cardiac hypertrophy

Biochemical and Biophysical Research Communications

Volumn 428, Issue 1, 2012, Pages 191-196

  Jeong, Moon Hee ^a   Lee, Jong Sub ^a   Kim, Do Han ^a   Park, Woo Jin ^a   Yang, Dong Kwon ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Cardiac hypertrophy; Cardiomyocytes; MicroRNA; Regression; Transverse aortic constriction

Indexed keywords

MICRORNA; MICRORNA 101B; MICRORNA 142; MICRORNA 181D; MICRORNA 24; MICRORNA 450A; PHENYLEPHRINE; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SIZE; CONTROLLED STUDY; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REMISSION; UPREGULATION;

ANIMALS; CARDIOMEGALY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; MICRORNAS; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84868347665     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.040     Document Type: Article

References (21)

1. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nature Reviews Molecular Cell Biology 2006, 7:589-600.
2. Dorn G.W., Robbins J., Sugden P.H. Phenotyping hypertrophy: eschew obfuscation. Circulation Research 2003, 92:1171-1175.
3. Hunter J.J., Chien K.R. Signaling pathways for cardiac hypertrophy and failure. The New England Journal of Medicine 1999, 341:1276-1283.
4. Katz A.M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. The New England Journal of Medicine 1990, 322:100-110.
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
6. Sayed D., Hong C., Chen I.Y., Lypowy J., Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circulation Research 2007, 100:416-424.
7. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:18255-18260.
8. Jentzsch C., Leierseder S., Loyer X., Flohrschutz I., Sassi Y., Hartmann D., Thum T., Laggerbauer B., Engelhardt S. A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. Journal of Molecular and Cellular Cardiology 2012, 52:13-20.
9. Small E.M., Frost R.J., Olson E.N. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010, 121:1022-1032.
10. Yang D.K., Choi B.Y., Lee Y.H., Kim Y.G., Cho M.C., Hong S.E., Kim do H., Hajjar R.J., Park W.J. Gene profiling during regression of pressure overload-induced cardiac hypertrophy. Physiological Genomics 2007, 30:1-7.
11. Sadoshima J., Jahn L., Takahashi T., Kulik T.J., Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. The Journal of Biological Chemistry 1992, 267:10551-10560.
12. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. The New England Journal of Medicine 1990, 322:1561-1566.
13. Frey N., Olson E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annual Review of Physiology 2003, 65:45-79.
14. Hardt S.E., Sadoshima J. Negative regulators of cardiac hypertrophy. Cardiovascular Research 2004, 63:500-509.
15. Gladka M.M., da Costa Martins P.A., De Windt L.J. Small changes can make a big difference - microRNA regulation of cardiac hypertrophy. Journal of Molecular and Cellular Cardiology 2012, 52:74-82.
16. Lee S.H., Yang D.K., Choi B.Y., Lee Y.H., Kim S.Y., Jeong D., Hajjar R.J., Park W.J. The transcription factor Eya2 prevents pressure overload-induced adverse cardiac remodeling. Journal of Molecular and Cellular Cardiology 2009, 46:596-605.
17. Zhu H., Yang Y., Wang Y., Li J., Schiller P.W., Peng T. MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovascular Research 2011, 92:75-84.
18. Qin B., Xiao B., Liang D., Xia J., Li Y., Yang H. MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochemical and Biophysical Research Communications 2011, 410:127-133.
19. Lu Z., Li Y., Takwi A., Li B., Zhang J., Conklin D.J., Young K.H., Martin R. miR-301a as an NF-kappaB activator in pancreatic cancer cells. The EMBO Journal 2011, 30:57-67.
20. Sarkar S., Dey B.K., Dutta A. MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Molecular Biology of the Cell 2010, 21:2138-2149.
21. Yang Y., Ago T., Zhai P., Abdellatif M., Sadoshima J. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circulation Research 2011, 108:305-313.